FORA Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,678
Closed -$815K 476
2025
Q4
$815K Buy
+7,678
New +$890K 0.1% 232
2025
Q3
Sell
-13,377
Closed -$1.64M 541
2025
Q2
$1.64M Buy
+13,377
New +$1.53M 0.18% 142
2025
Q1
Sell
-11,864
Closed -$1.1M 539
2024
Q4
$1.1M Buy
+11,864
New +$1.16M 0.13% 191
2022
Q4
Sell
-7,707
Closed -$349K 523
2022
Q3
$349K Sell
7,707
-1,973
-20% -$98.7K 0.07% 304
2022
Q2
$432K Buy
+9,680
New +$497K 0.09% 274
2021
Q1
Sell
-4,892
Closed -$322K 859
2020
Q4
$322K Buy
+4,892
New +$288K 0.05% 391
2020
Q3
Sell
-6,100
Closed -$301K 733
2020
Q2
$301K Buy
+6,100
New +$329K 0.1% 250
2020
Q1
Sell
-10,652
Closed -$587K 1110
2019
Q4
$587K Buy
+10,652
New +$578K 0.06% 362

Other funds holding EHC

FORA Capital's EHC Position: Q1 2026 in Review

FORA Capital sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 7,678 shares — an estimated $815K sold.

FORA Capital first reported a position in EHC in Q4 2019 and held it in 8 quarters. The position peaked at $1.64M in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • FORA Capital reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 7,678 Encompass Health shares in Q1 2026, an estimated $815K.
  • FORA Capital first reported a position in Encompass Health in Q4 2019 and held it in 8 quarters.
  • FORA Capital's Encompass Health position peaked at $1.64M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.